New chapter at PHI as Eschricht resumes CEO role

The leadership change comes as Phase Holographic Imaging (PHI) advances toward the market launch of HoloMonitor CellSync, a next-generation live cell imaging system.

CellSync is currently undergoing pre-production testing at the Huntsman Cancer Institute and the Wake Forest Institute for Regenerative Medicine, two prestigious research centers in the United States. It is the first in.